skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Mostrar Somente
Refinado por: assunto: Apoptosis remover assunto: Health Aspects remover Cancer remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells
A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells

Ray, A ; Das, D S ; Song, Y ; Macri, V ; Richardson, P ; Brooks, C L ; Chauhan, D ; Anderson, K C

Leukemia, 2017-12, Vol.31 (12), p.2652-2660 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Arsenic trioxide and triptolide synergistically induce apoptosis in the SKM-1 human myelodysplastic syndrome cell line
Arsenic trioxide and triptolide synergistically induce apoptosis in the SKM-1 human myelodysplastic syndrome cell line
Material Type:
Artigo 		Adicionar ao Meu Espaço

Arsenic trioxide and triptolide synergistically induce apoptosis in the SKM-1 human myelodysplastic syndrome cell line

Hua, Hai-Ying ; Gao, Hua-Qiang ; Sun, Ai-Ning ; Cen, Jian-Nong ; Wu, Li-Li

Molecular medicine reports, 2016-11, Vol.14 (5), p.4180-4186 [Periódico revisado por pares]

Greece: D.A. Spandidos

Texto completo disponível

Citações Citado por
3
Aurora kinase inhibitor VX‑680 suppresses the proliferation and migration of HUVECs and angiogenesis
Aurora kinase inhibitor VX‑680 suppresses the proliferation and migration of HUVECs and angiogenesis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Aurora kinase inhibitor VX‑680 suppresses the proliferation and migration of HUVECs and angiogenesis

Sun, Xuejiao ; Niu, Shishi ; Zhang, Zhen ; Wang, Anyan ; Yang, Chengyuan ; Guo, Zichan ; Hao, Yuepeng ; Li, Xiaozhong ; Wang, Xiaoxia

Molecular medicine reports, 2019-05, Vol.19 (5), p.3841-3847

Greece: Spandidos Publications

Texto completo disponível

Citações Citado por
4
EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers

Alldredge, Jill K ; Eskander, Ramez N

Gynecologic oncology research and practice, 2017-10, Vol.4 (1), p.17, Article 17 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
5
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia

Brzezinka, Krzysztof ; Nevedomskaya, Ekaterina ; Lesche, Ralf ; Steckel, Michael ; Eheim, Ashley L ; Haegebarth, Andrea ; Stresemann, Carlo

Journal of hematology and oncology, 2019-06, Vol.12 (1), p.66-66, Article 66 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
6
Ganetespib: research and clinical development
Ganetespib: research and clinical development
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ganetespib: research and clinical development

Jhaveri, Komal ; Modi, Shanu

OncoTargets and therapy, 2015-01, Vol.8 (default), p.1849-1858 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

Citações Citado por
7
GSK-3: a multifaceted player in acute leukemias
GSK-3: a multifaceted player in acute leukemias
Material Type:
Artigo 		Adicionar ao Meu Espaço

GSK-3: a multifaceted player in acute leukemias

Martelli, Alberto M ; Evangelisti, Camilla ; Paganelli, Francesca ; Chiarini, Francesca ; McCubrey, James A

Leukemia, 2021-07, Vol.35 (7), p.1829-1842 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Homoharringtonine Exerts an Antimyeloma Effect by Promoting Excess Parkin-Dependent Mitophagy
Homoharringtonine Exerts an Antimyeloma Effect by Promoting Excess Parkin-Dependent Mitophagy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Homoharringtonine Exerts an Antimyeloma Effect by Promoting Excess Parkin-Dependent Mitophagy

Zhang, Yanyu ; Huang, Ning ; Xu, Jie ; Zheng, Wei ; Cui, Xing

Drug design, development and therapy, 2020-01, Vol.14, p.4749-4763 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

Citações Citado por
9
Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9
Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9

Secker, Kathy-Ann ; Keppeler, Hildegard ; Duerr-Stoerzer, Silke ; Schmid, Hannes ; Schneidawind, Dominik ; Hentrich, Thomas ; Schulze-Hentrich, Julia M ; Mankel, Barbara ; Fend, Falko ; Schneidawind, Corina

Oncogene, 2019-11, Vol.38 (46), p.7181-7195 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity

Quotti Tubi, Laura ; Gurrieri, Carmela ; Brancalion, Alessandra ; Bonaldi, Laura ; Bertorelle, Roberta ; Manni, Sabrina ; Pavan, Laura ; Lessi, Federica ; Zambello, Renato ; Trentin, Livio ; Adami, Fausto ; Ruzzene, Maria ; Pinna, Lorenzo A ; Semenzato, Gianpietro ; Piazza, Francesco

Journal of hematology and oncology, 2013-10, Vol.6 (1), p.78-78, Article 78 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (18)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.